http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07101969-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ba951f64bbf542540ba2e7659fec96c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa6e4421d9e1159b6012d9bf702be572 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 |
| filingDate | 1993-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025f7a52f22aeb82fea1d87086bb742a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee4efb2fef15f020b09dddb17f5119d6 |
| publicationDate | 1995-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H07101969-A |
| titleOfInvention | Fat-soluble halogen platinum (IV) complex of antitumor cyclohexanediamine derivative |
| abstract | (57) [Summary] [Purpose] It is an object of the present invention to provide a novel and excellent antitumor property, particularly a platinum complex effective for organ tumor. [Constitution] The following general formula A lipophilic halogen platinum (IV) complex of an antitumor cyclohexanediamine derivative represented by: Note that -AA is 1, 2 -Cycloalkanediamine, 2-aminomethylcyclohexylamine, 1,1-aminomethylcyclohexane, It is a kind selected from O-phenylenediamine, ethylenediamine or propylenediamine, and X is a kind selected from bromine, iodine or fluorine. |
| priorityDate | 1993-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.